House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
House Oversight Committee to Hold Hearing on Gilead’s Exorbitant Price for HIV Prevention Drug – On Thursday, May 16, 2019, at 10:00 a.m., the Committee on Oversight and Reform will hold a hearing on “HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments.”
FY20 House Labor-HHS Appropriations Summary (Upcoming Fiscal Year) – On April 29, 2019, the House Appropriations Committee released the draft fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies (LHHS) funding bill, which included the following funds for federal HIV programs
Week ending: April 5, 2019 By: Sable K. Nelson Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy for HIV Pre-Exposure Prophylaxis On April […]
